The Best Omics Data Analysis Software for Your Own Data

For a single person’s data, the best answer is a small set of free command-line tools glued together by a workflow manager. Use bcftools and hail or plink2 for variants, salmon or STAR plus DESeq2 for RNA, and FragPipe or the still-free MaxQuant for mass-spectrometry proteomics. For biomarkers and continuous glucose data, use plain Python with pandas and statsmodels. Wrap the whole thing in Nextflow or Snakemake, pin versions in a container, and integrate across layers at the end with MOFA2. The web platforms that dominate search results are useful for group comparisons in a cohort study. They are a poor fit for n=1 longitudinal data, because almost every statistic they compute assumes you have replicates across samples that differ by condition.

That is the short answer. The rest of this page explains why each choice wins at its layer, what the flags do, and where things break.

What “omics data analysis” means in practice

Omics analysis is the process of turning instrument output into a table of quantified molecular features, then asking statistical questions of that table. Every layer has the same two stages. First, primary processing: base calls to alignments to variants, or spectra to peptides to protein groups. Second, secondary analysis: normalization, differential testing, dimensionality reduction, and annotation.

The two stages have different tooling economics. Primary processing is well solved, computationally heavy, and should be run once with a pinned pipeline. Secondary analysis is where judgment lives, and where you will iterate dozens of times. The software directories and review literature are long precisely because the secondary stage has no single correct method ¹².

The failure mode we see most often is people spending their effort on the primary stage, which is mostly a solved engineering problem, and then running secondary analysis inside a point-and-click tool that hides its assumptions.

Genome: bcftools, plink2, and a good annotator

Your whole-genome data arrives as FASTQ (raw reads), CRAM or BAM (alignments), and VCF or gVCF (variant calls). Keep the CRAM. It is roughly 15-20 GB for a 30x human genome, versus about 60 GB for BAM, and you will need it any time you want to re-examine a specific locus.

Use bcftools for everything that is a per-record operation. bcftools view -f PASS -i 'FORMAT/DP>10 & FORMAT/GQ>20' removes the low-confidence calls that otherwise dominate any list you generate. For genotype-level work at scale, plink2 --pfile is dramatically faster than VCF text parsing, though you lose multi-allelic fidelity in the conversion. Annotate with VEP or bcftools csq, with a local cache rather than the REST API. The REST endpoint will rate-limit you at about the 10,000th variant.

Two specific traps. First, coordinate systems: GRCh38 and GRCh37 positions are not interchangeable, and pharmacogenomic and ClinVar resources are still published against both. Check the header before you look anything up. Second, low-complexity and segmental-duplication regions produce large numbers of spurious calls. Intersect against the GA4GH high-confidence regions with bedtools intersect before you believe any single novel variant.

Interpretation of a specific variant is a clinical question. If something looks medically meaningful, take it to a genetic counselor or physician for confirmatory testing in an accredited lab.

Transcriptome: salmon for quantification, DESeq2 for structure

For RNA sequencing, we use salmon in selective-alignment mode: salmon quant -i idx -l A --validateMappings --seqBias --gcBias -1 r1.fq.gz -2 r2.fq.gz. It runs in minutes on a laptop-class machine and the GC-bias correction matters when library prep differs between draws. Build the index on a decoy-aware transcriptome, or intronic and intergenic reads get assigned to transcripts they did not come from.

Then import with tximport and hand counts to DESeq2. In the n=1 longitudinal setting, you are not doing a two-group comparison. You have a time series of one person, so the useful model is ~ timepoint on variance-stabilized counts, or a spline term if you have six or more draws. Read the vst() output, not raw TPM, for any clustering or correlation work.

Expect whole blood to be dominated by immunoglobulin and hemoglobin transcripts. A single acute infection will swamp everything else in your top-variable-gene list. Deconvolve cell-type composition with CIBERSORTx or xCell before you conclude that a pathway changed, because most blood expression change is a change in cell proportions.

Proteomics: FragPipe, and yes, MaxQuant is free

MaxQuant is free for academic and commercial use, downloadable after registration, and still the reference implementation for label-free quantification. We prefer FragPipe today. It wraps MSFragger for search, Philosopher for filtering and IonQuant for quantification. On the same data it is roughly an order of magnitude faster. For data-independent acquisition runs, DIA-NN or FragPipe’s DIA module are the practical choices.

A few parameters change your answer. The first is precursor mass tolerance, at 20 ppm for modern orbitraps. The second is the decoy-based false discovery rate threshold, set to 1% at both peptide and protein level rather than peptide alone. The third is match-between-runs, which raises identification counts and also raises the risk of propagating a bad identification across your whole time series. Turn it on, then verify your key proteins have direct evidence in at least one run.

Normalization is the decision that most affects downstream results, and it is underrated. Median or quantile normalization, variance-stabilizing normalization, and no normalization at all can produce materially different feature rankings on the same matrix. There is published methodology for choosing among them empirically using supervised and unsupervised performance rather than by convention ³. Do that selection once, write it down, and then apply the same choice to every future draw.

If your proteomics is affinity-based (Olink or SomaScan) rather than mass spectrometry, none of the above applies. You get a normalized table directly, in Olink’s case on a log2 scale. The relevant concern becomes cross-batch bridging, and you should request the bridging samples from the vendor.

Integration: MOFA2, and being plain about what it can do

Multi-omics integration methods fall into a few families: concatenation-based, transformation-based and model-based. Each family makes different assumptions about how layers relate ⁴. For a single person’s longitudinal data, we use MOFA2. It fits latent factors shared across layers and tells you how much variance each factor explains in each view. mixOmics DIABLO is the alternative, but it is supervised and wants class labels you do not have.

Be realistic about sample size. MOFA2 needs on the order of 10 or more timepoints before the factors are stable, and it will happily return factors from five. Run it, check the variance-explained plot, and discard any factor that loads on a single view. Those are usually batch effects.

Metabolomics, if you add it, brings its own integration difficulty. Feature identification is incomplete, so a large share of your peaks have no annotation and cannot be mapped to a pathway ⁵. Plan for that rather than being surprised by it.

The pipeline layer, which matters more than the tools

Pick Nextflow or Snakemake and use it for everything. The nf-core project gives you production pipelines (nf-core/sarek for germline variants, nf-core/rnaseq for expression) that already encode the flags argued about above. Pin the revision with -r 3.14.0 and pin containers, because reproducibility across reruns is the whole point of using a framework ⁶.

Galaxy is the right recommendation for a specific reader: someone who wants a graphical interface, has no compute, and needs the provenance record. It handles genomic, transcriptomic, and proteomic workflows in one environment and records every parameter ⁷. The cost is friction when you need a tool version it does not package.

Zero-code web platforms like OmicShare or PMart earn their place for exploratory plotting and for handing results to a collaborator who does not write code ⁸⁹. Use them for the last mile. Do not use them for the statistics, because you cannot audit or version what they ran.

Questions people also ask

What is the best free data analysis software for omics?

R with Bioconductor, for secondary analysis, and Nextflow with nf-core for primary processing. Both are free, both are the versions of record in the literature, and both leave an auditable script behind. Python with scanpy, pandas, and statsmodels is an equally good choice if that is your language.

Is MaxQuant free to use?

Yes. MaxQuant is free to download and use, including commercially, after registering on the developer’s site. It runs natively on Windows and works under Linux with .NET, and the associated Perseus tool for downstream statistics is also free.

What software can I use for proteomics analysis?

Use FragPipe for search and quantification of data-dependent runs, DIA-NN for data-independent acquisition, and MaxQuant if you want the established reference. For differential testing, use limma or MSstats in R. For visualization and quick statistics without coding, Perseus or PMart ⁹.

Do I need a cluster?

No. A 32 GB machine with 8 cores and about 2 TB of disk will run salmon, bcftools, and FragPipe on one person’s data comfortably. Genome alignment from FASTQ is the one step worth renting a larger instance for, and you only do it once.

Footnotes

1. V. J. Henry, A. E. Bandrowski, A.-S. Pepin, et al. OMICtools: an informative directory for multi-omic data analysis. Database, 2014. https://doi.org/10.1093/database/bau069 ↩

2. Bonnie Berger, Jian Peng, Mona Singh. Computational solutions for omics data. Nature Reviews Genetics, 2013. https://doi.org/10.1038/nrg3433 ↩

3. Aleesa E. Chua, Leah D. Pfeifer, Emily R. Sekera, et al. Workflow for Evaluating Normalization Tools for Omics Data Using Supervised and Unsupervised Machine Learning. Journal of the American Society for Mass Spectrometry, 2023. https://doi.org/10.1021/jasms.3c00295 ↩

4. Indhupriya Subramanian, Srikant Verma, Shiva Kumar, et al. Multi-omics Data Integration, Interpretation, and Its Application. Bioinformatics and Biology Insights, 2020. https://doi.org/10.1177/1177932219899051 ↩

5. Alice Cambiaghi, Manuela Ferrario, Marco Masseroli. Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration. Briefings in Bioinformatics, 2016. https://doi.org/10.1093/bib/bbw031 ↩

6. Kathleen M. Fisch, Tobias Meißner, Louis Gioia, et al. Omics Pipe: a community-based framework for reproducible multi-omics data analysis. Bioinformatics, 2015. https://doi.org/10.1093/bioinformatics/btv061 ↩

7. Jorrit Boekel, John M Chilton, Ira R Cooke, et al. Multi-omic data analysis using Galaxy. Nature Biotechnology, 2015. https://doi.org/10.1038/nbt.3134 ↩

8. Hongyan Mu, Jianzhou Chen, Wenjie Huang, et al. OmicShare tools: A zero‐code interactive online platform for biological data analysis and visualization. iMeta, 2024. https://doi.org/10.1002/imt2.228 ↩

9. Kelly G. Stratton, Daniel M. Claborne, David J. Degnan, et al. PMart Web Application: Marketplace for Interactive Analysis of Panomics Data. Journal of Proteome Research, 2023. https://doi.org/10.1021/acs.jproteome.3c00512 ↩ ↩²